Presentation THT 2025 Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies Presenter: David Cohen February 13, 2025
Presentation THT 2025 This Strategy Has Saved the Startup Medical Device Sector Presenter: William Abraham February 13, 2025
Presentation THT 2025 Down-Stream Challenges: Reimbursement and Guidelines Presenter: Philip Adamson February 13, 2025
Presentation THT 2025 Position 2: All You Need Is Rate Control Presenter: Akshay Desai February 12, 2025
Presentation THT 2025 Challenges in Designing Collaborative Clinical Therapeutic Trials in HT Presenter: Jeffrey Teuteberg February 12, 2025
Presentation THT 2025 A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial Presenter: Akshay Desai February 12, 2025
Presentation THT 2025 Under Pressure: The Relationship Between Ambulatory PA Pressure and Mortality in Chronic Heart Failure Presenter: Akshay Desai February 12, 2025
Presentation THT 2025 FINEARTS-HF Design and Principal Results in Context Presenter: Akshay Desai February 12, 2025
Presentation THT 2025 Alleviant Implant Free Shunt: Learning and Adapting in Device and Trial Design Presenter: James Udelson February 12, 2025
Presentation THT 2025 A Device Designed for Patient Comfort - BrioVAD Presenter: Jim Long February 12, 2025
Presentation THT 2025 Heart Failure Management Using a Risk Score From an Insertable Cardiac Monitor: The Rationale and Design of the ALLEVIATE-HF Trial Presenter: Javed Butler February 11, 2025
Presentation THT 2025 Are Wearables and Smart Devices a More Scalable Solution Presenter: Akshay Desai February 11, 2025
Presentation THT 2024 New Endpoints and Experimental Designs for Devices for Chronic Heart Failure (Breakthrough) Presenter: William T. Abraham March 06, 2024
Presentation THT 2024 A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms. Presenter: Thomas Hanff March 06, 2024
Presentation THT 2024 Remote PA Pressure Monitoring: Where are we now and where are we going? Presenter: Akshay Desai March 05, 2024
Presentation THT 2024 Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers Presenter: Harriette G.C. Van Spall March 05, 2024
Presentation THT 2024 A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1 Presenter: Lothar Roessig March 05, 2024
Presentation THT 2024 Remote Patient Monitoring: Implications for Management of HF Patients During the Next Decade Presenter: Akshay Desai March 05, 2024
Presentation THT 2024 Inhibition of Hepatic Angiotensinogen Synthesis by an RNA Interference Therapeutic Agent: Implications for HTN and HF Presenter: Akshay Desai March 05, 2024